251 related articles for article (PubMed ID: 24415867)
1. Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis.
Zhang Y; Shi ZL; Yang X; Yin ZF
World J Gastroenterol; 2014 Jan; 20(1):142-7. PubMed ID: 24415867
[TBL] [Abstract][Full Text] [Related]
2. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
3. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
[TBL] [Abstract][Full Text] [Related]
4. Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood.
Wang Z; Luo L; Cheng Y; He G; Peng B; Gao Y; Jiang ZS; Pan M
J Gastrointest Surg; 2018 Apr; 22(4):633-639. PubMed ID: 29159757
[TBL] [Abstract][Full Text] [Related]
5. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
[TBL] [Abstract][Full Text] [Related]
6. Anterior Approach to Improve the Prognosis in HCC Patients Via Decreasing Dissemination of EpCAM
Hao S; Chen S; Tu C; Huang T
J Gastrointest Surg; 2017 Jul; 21(7):1112-1120. PubMed ID: 28378318
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.
Zhang Y; Zhang X; Zhang J; Sun B; Zheng L; Li J; Liu S; Sui G; Yin Z
Cancer Biol Ther; 2016 Nov; 17(11):1177-1187. PubMed ID: 27662377
[TBL] [Abstract][Full Text] [Related]
8. The Research of No-Touch Isolation Technique on the Prevention of Postoperative Recurrence and Metastasis of Hepatocellular Carcinoma after Hepatectomy.
Li Y; Xu KS; Li JS; Jia WD; Liu WB; He XD; Xu GL
Hepatogastroenterology; 2014 May; 61(131):784-91. PubMed ID: 26176074
[TBL] [Abstract][Full Text] [Related]
9. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells.
Lai HC; Yeh CC; Jeng LB; Huang SF; Liao PY; Lei FJ; Cheng WC; Hsu CL; Cai X; Chang C; Ma WL
Oncotarget; 2016 Jul; 7(29):46448-46465. PubMed ID: 27340775
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
[TBL] [Abstract][Full Text] [Related]
12. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
Zhao L; Zheng Z; Liu Y; Liu F; Li X; Wu Z
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6035-6048. PubMed ID: 36633681
[TBL] [Abstract][Full Text] [Related]
13. AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis.
Jin J; Niu X; Zou L; Li L; Li S; Han J; Zhang P; Song J; Xiao F
Cancer Lett; 2016 Aug; 378(1):33-7. PubMed ID: 27160647
[TBL] [Abstract][Full Text] [Related]
14. Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection.
Sun YF; Wang PX; Cheng JW; Gong ZJ; Huang A; Zhou KQ; Hu B; Gao PT; Cao Y; Qiu SJ; Zhou J; Fan J; Guo W; Yang XR
Cancer Cytopathol; 2020 Oct; 128(10):733-745. PubMed ID: 32501632
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant systemic drug therapy and recurrence of hepatocellular carcinoma following curative resection.
Zhong Y; Liu B; Deng M; Xu R
Drug Discov Ther; 2013 Aug; 7(4):164-6. PubMed ID: 24071579
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
Chen J; Cao SW; Cai Z; Zheng L; Wang Q
Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
[TBL] [Abstract][Full Text] [Related]
17. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.
Yin LC; Luo ZC; Gao YX; Li Y; Peng Q; Gao Y
Biomed Res Int; 2018; 2018():3789613. PubMed ID: 30046595
[TBL] [Abstract][Full Text] [Related]
18. Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy.
Lu Z; Ni H; Yang X; Tan L; Zhuang H; Mo Y; Wei X; Qi L; Xiang B
BMC Cancer; 2023 Nov; 23(1):1150. PubMed ID: 38012581
[TBL] [Abstract][Full Text] [Related]
19. pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.
Li J; Shi L; Zhang X; Sun B; Yang Y; Ge N; Liu H; Yang X; Chen L; Qian H; Wu M; Yin Z
Oncotarget; 2016 Jan; 7(3):2646-59. PubMed ID: 26544731
[TBL] [Abstract][Full Text] [Related]
20. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
